Einsatz von funktioneller Bildgebung zur Therapieplanung

  • Abstract
  • References
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

Einsatz von funktioneller Bildgebung zur Therapieplanung

Note: looks like a niche area of research and we don't have enough papers to generate a graph.
ReferencesShowing 10 of 54 papers
  • Open Access Icon
  • PDF Download Icon
  • Cite Count Icon 44
  • 10.1007/s00259-020-04827-6
Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
  • Jan 1, 2020
  • European Journal of Nuclear Medicine and Molecular Imaging
  • Simon Spohn + 11 more

  • Open Access Icon
  • Cite Count Icon 63
  • 10.2174/1874471013666191223153755
FDG PET/CT in the Staging of Lung Cancer.
  • Nov 30, 2020
  • Current Radiopharmaceuticals
  • Mohsen Farsad

  • Cite Count Icon 2
  • 10.1053/j.semnuclmed.2025.02.004
Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends.
  • Mar 1, 2025
  • Seminars in nuclear medicine
  • Sobhan Vinjamuri + 1 more

  • Cite Count Icon 2
  • 10.1016/j.eururo.2025.01.003
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care.
  • Apr 1, 2025
  • European urology
  • Vedang Murthy + 17 more

  • Open Access Icon
  • Cite Count Icon 185
  • 10.2967/jnumed.117.191031
PSMA Ligands for PET Imaging of Prostate Cancer.
  • Jul 7, 2017
  • Journal of Nuclear Medicine
  • Sarah M Schwarzenboeck + 8 more

  • Open Access Icon
  • Cite Count Icon 37
  • 10.3390/cancers13225795
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial.
  • Nov 18, 2021
  • Cancers
  • Constantinos Zamboglou + 15 more

  • Cite Count Icon 21
  • 10.1021/acs.molpharmaceut.8b01210
Targeting CAIX with [64Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice.
  • Feb 25, 2019
  • Molecular Pharmaceutics
  • Xianteng Yang + 11 more

  • Open Access Icon
  • Cite Count Icon 57
  • 10.2967/jnumed.119.233809
Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis.
  • Sep 20, 2019
  • Journal of Nuclear Medicine
  • Paul L De Zwart + 6 more

  • Open Access Icon
  • Cite Count Icon 56
  • 10.2967/jnumed.114.144253
Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
  • Jan 8, 2015
  • Journal of Nuclear Medicine
  • Jérémie Calais + 6 more

  • Open Access Icon
  • Cite Count Icon 1
  • 10.1186/s40644-024-00774-9
Immune-related [18F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications
  • Sep 17, 2024
  • Cancer Imaging
  • Giulia Santo + 7 more

More from: best practice onkologie
  • Research Article
  • 10.1007/s11654-025-00696-3
onko-aktuell
  • Oct 22, 2025
  • best practice onkologie

  • Research Article
  • 10.1007/s11654-025-00697-2
Sequenztherapie des metastasierten kolorektalen Karzinoms
  • Oct 21, 2025
  • best practice onkologie
  • Arndt Stahler + 3 more

  • Research Article
  • 10.1007/s11654-025-00694-5
Wichtige Studien vom ASCO 2025
  • Oct 6, 2025
  • best practice onkologie
  • Bernhard Wörmann

  • Research Article
  • 10.1007/s11654-025-00689-2
Einsatz von funktioneller Bildgebung zur Therapieplanung
  • Oct 1, 2025
  • best practice onkologie
  • P M A Waibel + 7 more

  • Research Article
  • 10.1007/s11654-025-00692-7
Editorial
  • Oct 1, 2025
  • best practice onkologie
  • Stephan Schmitz

  • Research Article
  • 10.1007/s11654-025-00685-6
Organerhaltende Therapie des muskelinvasiven Harnblasenkarzinoms
  • Sep 22, 2025
  • best practice onkologie
  • Oliver J Ott

  • Research Article
  • 10.1007/s11654-025-00691-8
Der erste Schritt zur kontextbewussten Medizin ist das Aufdecken der „blinden Flecken“
  • Sep 19, 2025
  • best practice onkologie

  • Research Article
  • 10.1007/s11654-025-00693-6
onko-aktuell
  • Sep 19, 2025
  • best practice onkologie

  • Research Article
  • 10.1007/s11654-025-00687-4
Für Strategie bleibt da keine Zeit
  • Sep 12, 2025
  • best practice onkologie

  • Research Article
  • 10.1007/s11654-025-00684-7
Wichtige Studien vom ASCO 2025
  • Sep 9, 2025
  • best practice onkologie
  • Bernhard Wörmann

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.

Search IconWhat is the difference between bacteria and viruses?
Open In New Tab Icon
Search IconWhat is the function of the immune system?
Open In New Tab Icon
Search IconCan diabetes be passed down from one generation to the next?
Open In New Tab Icon